Trader consensus assigns a 78% implied probability to "No," driven by the CDC's ongoing absence of any Level 4 "Avoid All Travel" Travel Health Notices—the highest tier reserved for destinations posing extreme, life-threatening health risks—and no active Level 3 alerts either. Recent developments, including the March 2026 expansion of the Level 2 Global Polio notice to countries like Laos and Namibia amid circulating poliovirus, have not prompted escalation, as epidemiological data shows vaccination efforts containing spread without widespread paralysis cases. CDC public health risk assessments for avian influenza A(H5N1) remain low, lacking evidence of sustained human-to-human transmission. With seven months until resolution, traders eye weekly CDC surveillance updates and WHO reports for potential shifts from novel pathogens, though historical rarity of Level 4 issuances reinforces the current positioning.